CN1086298C - Ointment for rheumatic spur - Google Patents
Ointment for rheumatic spur Download PDFInfo
- Publication number
- CN1086298C CN1086298C CN99116404A CN99116404A CN1086298C CN 1086298 C CN1086298 C CN 1086298C CN 99116404 A CN99116404 A CN 99116404A CN 99116404 A CN99116404 A CN 99116404A CN 1086298 C CN1086298 C CN 1086298C
- Authority
- CN
- China
- Prior art keywords
- radix
- herba
- rhizoma
- root
- spurs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to an ointment for rheumatic spurs, which uses Chinese angelica root-tip, safflower, peach kernel, rhizome of Sichuan lovage, milletol stem, RuMo, panax notoginseng, fox glove, herba cistanch, psoralea fruit, deglued antler powder, keel, rhizome of drynaria, epimedium, cibot rhizome, eucommia bark, blood notoginseng, cistanche stem, psoralea seed, cohosh root, money root, atractylodes rhizome, dahurian angelica root, asarum herb, beautiful millettia root, philippine flemingia root, notopterygium root, pubescent angelica root, radix aconiti, wild aconite, slteeophaga plancyi, centipede and Chinese ephedra as raw materials; the raw materials are refined to paste according to the traditional methods, then the paste is spread on hard paper, and the ointment for rheumatic spurs can be obtained. The ointment for rheumatic spurs is used for treating rheumatism and spurs; the ointment for rheumatic spurs is pasted at ill parts so that medicines are directly impregnated into periosteum and bone focus parts through skin, mucosae, muscular layers and capillaries; and thereby, the effects that the spurs are gradually shrunk and softened are realized. The present invention has the advantages of favorable curative effect and no recurrence after cure.
Description
The present invention relates to the external application medicine with the Chinese medicine preparation of medicine.
Cervical spondylosis, lumbar spondylosis, prolapse of lumbar intervertebral disc, sciatica, knee hyperplasia, each position hyperosteogeny is commonly called as bony spur.Be the common frdquently encountered disease of middle-aged and elderly people, especially more general in personnel's morbidity of office work, it is the difficult pertinacious disease in orthopaedics field.Its main clinical manifestation is that acid is expanded, numbness, pain, limb function are limited, if mistake is controlled or delay treatment, the lighter causes disorder of limb ' s activity, and weight person causes paralysis, and people's physical and mental health is caused very big misery.
At present, treating above-mentioned disease does not all have good method or medicine, and prior treatment method mainly is physiotherapys such as traction, acupuncture-moxibustion, physical therapy, massage, massage, though can become flexible muscles and bones, the pain of releiving can not get radical cure, and often touching difficulty more.
The existing medicine that uses mainly is " Musk Analgesic Plaster ", " SUANTONG LING ", " bony spur liquid ", " pain-relieving liquid ", " KANGGU ZENGSHENG WAN " etc., all is to be main target with the eliminate pain, and the course of treatment is long, general 50 days is a course of treatment, and 3 to 5 courses of treatment are produce effects, and only effective to light disease.And oral drugs are transported to focus portion again through the blood circulation liver detoxification, and its active ingredient remains little, and effect lowers, and bigger to gastric irritation, and the curative effect instability can only be taken stopgap measures, and can not effect a permanent cure.
Purpose of the present invention is to provide a kind of with the Chinese medicine preparation, in the mode of externally applied plaster, the treatment rheumatism, the ointment for rheumatic spur of hyperosteogeny neck, shoulder, lumbar spondylosis makes medicine pass through skin, mucosa, flesh layer, blood capillary, directly be penetrated into periosteum, sclerotin focus portion, strong osmotic, blood vessel dilating improves blood capillary in focal zone microcirculation, the expansion bone, Haversian canal, strengthen the bone intracellular metabolic, reach and improve nutriture in the skeleton, and reach the purpose of treatment rheumatism involving the bone.
The present invention realizes its purpose by following prescription.
1. component and content: (consumption is %)
Radix Angelicae Sinensis 0.9-4.9% Flos Carthami 0.9-1.7% Semen Persicae 0.9-1.7%
Rhizoma Chuanxiong 0.9-1.7% Caulis seu Radix Schisandrae Henryi 0.9-1.7% breast does not have 0.9-5.2%
Radix Notoginseng 0.9-5.2% Radix Rehmanniae Preparata 2.6-5.2% Herba Cistanches 2.6-5.2%
Fructus Psoraleae 2.6-5.2% Cornu Cervi Degelatinatum 2.6-5.2% Os Draconis 2.6-5.2%
Rhizoma Drynariae 2.6-5.2% Herba Epimedii 1.7-3.5% Rhizoma Cibotii 1.7-5.2%
Cortex Eucommiae 1.7-5.2% XUESANQI 1.7-5.2% tap seven 1.7-5.2%
Kowtow sub seven 1.7-5.2% Radix Caulophylli 1.7-5.2% Herba Parnassiae Wightianae 1.7-2%
Rhizoma Atractylodis 1.7-5.2% Radix Angelicae Dahuricae 1.7-3.5% Herba Asari 1.7-3.5%
Millettia Speciosa 1.7-5.2% Radix Flemingiae Philippinensis 1.7-5.2% Rhizoma Et Radix Notopterygii 1.7-5.2%
Radix Angelicae Pubescentis 1.7-5.2% Radix Aconiti 1.7-5.2% Radix Aconiti Kusnezoffii 1.7-5.2%
Eupolyphoge sinensis 1.7-3.5% Scolopendra 1.7-3.5% Herba Ephedrae 1.7-5.2%
The formula optimization weight proportion scope of preparation medicine of the present invention is:
Radix Angelicae Sinensis 1-4% Flos Carthami 1-1.5% Semen Persicae 1-1.5%
Rhizoma Chuanxiong 1-1.5% Caulis seu Radix Schisandrae Henryi 1-1.5% breast does not have 1-5%
Radix Notoginseng 1-5% Radix Rehmanniae Preparata 3-5% Herba Cistanches 3-5%
Fructus Psoraleae 3-5% Cornu Cervi Degelatinatum 3-5% Os Draconis 3-5%
Rhizoma Drynariae 3-5% Herba Epimedii 2-3% Rhizoma Cibotii 2-5%
Cortex Eucommiae 2-5% XUESANQI 2-5% tap seven 2-5%
Kowtow sub seven 2-5% Radix Caulophylli 2-5% Herba Parnassiae Wightianae 1.7-2%
Rhizoma Atractylodis 2-5% Radix Angelicae Dahuricae 2-3% Herba Asari 2-3%
Millettia Speciosa 2-5% Radix Flemingiae Philippinensis 2-5% Rhizoma Et Radix Notopterygii 2-5%
Radix Angelicae Pubescentis 2-5% Radix Aconiti 2-5% Radix Aconiti Kusnezoffii 2-5%
Eupolyphoge sinensis 2-3% Scolopendra 2-3% Herba Ephedrae 2-5%
2. method for production
By traditional method, refine into cream, spread out on cardboard, topped thereon layer of transparent plastic sheeting is goods.
3. storage
The airtight shady and cool drying place that is positioned over, room temperature is preserved, and storage life is half a year.
4. usage and consumption
Thin film is opened, be applied to and wash the affected part of wiping away drying, whenever put up replacing on the three.One month is a course of treatment, and light disease person uses a course of treatment, three recoveries from illness course of treatment of serious symptom person.
The pharmacological mechanism of above-mentioned prescription:
Motherland's medical science is thought, the formation of hyperosteogeny, bony spur is that the human body sclerotin is aging, the result of regression, osteocyte multiple fission.The somebody thinks that hyperosteogeny and wind-cold damp pathogen have no relation, and the medicine of being developed is target with the pain relieving only, and does not have the meaning of wind dispelling expelling cold and dampness.Actually this is not so, and the invasion and attack of wind-cold damp pathogen are to cause hyperosteogeny, the key factor that bony spur forms." institute of heresy gathers, and its gas must be empty ", " wind-cold damp pathogen, three gas are assorted to be numbness to closing ", when human righteousness's deficiency, the wind-cold damp pathogen of impression is then taken advantage of a weak point, and invades fur muscles and bones, attacks into the meridians blood vessels, wound strain in addition, sclerotin is aging, makes B﹠J disease, cervical and lumbar diseases give birth to one after another.
Wind-cold damp pathogen is invaded the meridians blood vessels, goes for a long time and not, and numbness resistance meridians, stasis of blood plug is obstructed, stagnation of QI and blood may bring about pain, all pains are done.Wind-cold damp pathogen is invaded cervical region, then can cause cervical spondylosis, invades shoulder and then causes scapulohumeral periarthritis, invades waist and then can cause lumbago and skelalgia." General Treatise on the Cause and Symptoms of Diseases " " kidney master waist foot, kidney channel is deficient, air-cooledly takes advantage of it, so lumbago also ".The waist is a house of the kidney, kidney governing bones, living marrow, the then bone marrow scarcity of suffering from a deficiency of the kidney, skeleton loses supports, and then sclerotin is aging, and degeneration forms rheumatism involving the bone." strain in kidney, moving injury of meridian is invaded by cold wind again, and vim and vigour are hit and fought, so lumbago also ".Lumbago, hyperosteogeny are described, deficient with kidney channel, the wind-cold damp pathogen invasion and attack have substantial connection.So in treatment, when selecting anti-bone regeneration medicine for use, also use the medicine of a little wind-expelling and dispelling dampnesses, cold expelling, activating blood circulation and dissipating blood stasis, reducing swelling and alleviating pain, than use resisting hyperosteogeny medicine merely, curative effect improves greatly like this.
Advantage of the present invention is: from the etiology and pathology of hyperosteogeny, the side of executing selects medicine, both wind dispelling, cold expelling, damp eliminatings, the kidney invigorating again, replenishing essence, beneficial marrow, promoting blood circulation and detumescence pain relieving.Both eliminate, controlled the caused pain of hypertrophy bone, and can stop bony spur to form to resisting hyperosteogeny again.It is fast to be affixed on the affected part post-absorption, does not have allergy, and effect is lasting, has no side effect.Use by the course of treatment, can make bony spur reach atrophy, softening, the effect for the treatment of both the principal and secondary aspects of a disease gradually.
Model case:
Case one: it is surplus that Indonesia patient, Mr. Lian Yingxin suffer from cervical spondylosis 10 years, and neck is stiff to coagulate, limitation of activity, headache and dizzy, vexed insomnia, the acid of neck shoulder soft tissue is expanded and is felt bad, and right upper extremity is numb to expand, and once seeks medical advice in American-European, Japan, Singapore, the doctor advises its operation, and the patient fears operation, through the external application ointment for rheumatic spur, cervical vertebra bony spur for oral administration is loose, and a week promptly takes an evident turn for the better, two courses of treatment, neck-shoulder pain is eliminated, and the band medicine goes home to consolidate curative effect.
Case two: Longhua, Shenzhen patient, Mr. Wang Yiyu, prolapse of lumbar intervertebral disc 7 years, pain is unbearably, can not take care of oneself, the doctor advises its operation, and through the external application ointment for rheumatic spur, the prominent retraction of waist for oral administration is red, one all lumbago and skelalgia subtract greatly, and be cured three courses of treatment, and lumbago and skelalgia is from removing though operate on.
Provide two embodiment below in conjunction with the present invention:
Embodiment 1:
Radix Angelicae Sinensis 4% Flos Carthami 1.5% Semen Persicae 1.5% Rhizoma Chuanxiong 1.5%
Caulis seu Radix Schisandrae Henryi 1.5% breast does not have 2% Radix Notoginseng, 1.5% Radix Rehmanniae Preparata 4%
Herba Cistanches 4% Fructus Psoraleae 3% Cornu Cervi Degelatinatum 3% Os Draconis 5%
Rhizoma Drynariae 5% Herba Epimedii 2% Rhizoma Cibotii 3% Cortex Eucommiae 3%
XUESANQI 4% tap 7 4% is kowtowed son 7 4% Radix Caulophyllis 4%
Herba Parnassiae Wightianae 2% Rhizoma Atractylodis 5% Radix Angelicae Dahuricae 3% Herba Asari 3%
Millettia Speciosa 3% Radix Flemingiae Philippinensis 4% Rhizoma Et Radix Notopterygii 4% Radix Angelicae Pubescentis 2%
Radix Aconiti 3% Radix Aconiti Kusnezoffii 3.5% eupolyphoge sinensis 2% Scolopendra 2%
Herba Ephedrae 2%
By traditional method, refine into cream, spread out on cardboard, topped thereon layer of transparent plastic sheeting is goods.
Embodiment 2:
Radix Angelicae Sinensis 4% Flos Carthami 1.5% Semen Persicae 1.5% Rhizoma Chuanxiong 1%
Caulis seu Radix Schisandrae Henryi 1.5% breast does not have 2% Radix Notoginseng, 1% Radix Rehmanniae Preparata 3%
Herba Cistanches 3% Fructus Psoraleae 3% Cornu Cervi Degelatinatum 4% Os Draconis 4%
Rhizoma Drynariae 4% Herba Epimedii 3% Rhizoma Cibotii 3% Cortex Eucommiae 3%
XUESANQI 5% tap 7 5% is kowtowed son 7 5% Radix Caulophyllis 4%
Herba Parnassiae Wightianae 2% Rhizoma Atractylodis 4% Radix Angelicae Dahuricae 2% Herba Asari 3%
Millettia Speciosa 3.5% Radix Flemingiae Philippinensis 3% Rhizoma Et Radix Notopterygii 3% Radix Angelicae Pubescentis 3%
Radix Aconiti 3% Radix Aconiti Kusnezoffii 5% eupolyphoge sinensis 2% Scolopendra 2%
Herba Ephedrae 3%
By traditional method, refine into cream, spread out on cardboard, topped thereon layer of transparent plastic sheeting is goods.
Claims (2)
1. a plaster for the treatment of rheumatic spur is characterized in that, it is made by the following weight proportion raw material:
Radix Angelicae Sinensis 0.9-4.9% Flos Carthami 0.9-1.7% Semen Persicae 0.9-1.7%
Rhizoma Chuanxiong 0.9-1.7% Caulis seu Radix Schisandrae Henryi 0.9-1.7% breast does not have 0.9-5.2%
Radix Notoginseng 0.9-5.2% Radix Rehmanniae Preparata 2.6-5.2% Herba Cistanches 2.6-5.2%
Fructus Psoraleae 2.6-5.2% Cornu Cervi Degelatinatum 2.6-5.2% Os Draconis 2.6-5.2%
Rhizoma Drynariae 2.6-5.2% Herba Epimedii 1.7-3.5% Rhizoma Cibotii 1.7-5.2%
Cortex Eucommiae 1.7-5.2% XUESANQI 1.7-5.2% tap seven 1.7-5.2%
Kowtow sub seven 1.7-5.2% Radix Caulophylli 1.7-5.2% Herba Parnassiae Wightianae 1.7-2%
Rhizoma Atractylodis 1.7-5.2% Radix Angelicae Dahuricae 1.7-3.5% Herba Asari 1.7-3.5%
Millettia Speciosa 1.7-5.2% Radix Flemingiae Philippinensis 1.7-5.2% Rhizoma Et Radix Notopterygii 1.7-5.2%
Radix Angelicae Pubescentis 1.7-5.2% Radix Aconiti 1.7-5.2% Radix Aconiti Kusnezoffii 1.7-5.2%
Eupolyphoge sinensis 1.7-3.5% Scolopendra 1.7-3.5% Herba Ephedrae 1.7-5.2%
2. the plaster of treatment rheumatic spur according to claim 1, wherein the weight proportion of each raw material is:
Radix Angelicae Sinensis 1-4% Flos Carthami 1-1.5% Semen Persicae 1-1.5%
Rhizoma Chuanxiong 1-1.5% Caulis seu Radix Schisandrae Henryi 1-1.5% breast does not have 1-5%
Radix Notoginseng 1-5% Radix Rehmanniae Preparata 3-5% Herba Cistanches 3-5%
Fructus Psoraleae 3-5% Cornu Cervi Degelatinatum 3-5% Os Draconis 3-5%
Rhizoma Drynariae 3-5% Herba Epimedii 2-3% Rhizoma Cibotii 2-5%
Cortex Eucommiae 2-5% XUESANQI 2-5% tap seven 2-5%
Kowtow sub seven 2-5% Radix Caulophylli 2-5% Herba Parnassiae Wightianae 1.7-2%
Rhizoma Atractylodis 2-5% Radix Angelicae Dahuricae 2-3% Herba Asari 2-3%
Millettia Speciosa 2-5% Radix Flemingiae Philippinensis 2-5% Rhizoma Et Radix Notopterygii 2-5%
Radix Angelicae Pubescentis 2-5% Radix Aconiti 2-5% Radix Aconiti Kusnezoffii 2-5%
Eupolyphoge sinensis 2-3% Scolopendra 2-3% Herba Ephedrae 2-5%
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99116404A CN1086298C (en) | 1999-03-29 | 1999-03-29 | Ointment for rheumatic spur |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99116404A CN1086298C (en) | 1999-03-29 | 1999-03-29 | Ointment for rheumatic spur |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1231203A CN1231203A (en) | 1999-10-13 |
CN1086298C true CN1086298C (en) | 2002-06-19 |
Family
ID=5279225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN99116404A Expired - Fee Related CN1086298C (en) | 1999-03-29 | 1999-03-29 | Ointment for rheumatic spur |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1086298C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102018792B (en) * | 2010-11-19 | 2012-09-12 | 王丽华 | Traditional Chinese medicine for treating ankylosing spondylitis |
CN104491146A (en) * | 2014-12-18 | 2015-04-08 | 青岛百瑞吉生物工程有限公司 | Traditional Chinese ointment for treating hyperostosis as well as preparation method and application of traditional Chinese ointment |
-
1999
- 1999-03-29 CN CN99116404A patent/CN1086298C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1231203A (en) | 1999-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1118285C (en) | Shubi plaster for treating arthralgia due to wind-cold-dampness | |
CN1706441A (en) | Arthralgia treating plaster | |
CN1857541A (en) | Plaster for treating rheumatism and osteoarthrosis | |
CN1803187A (en) | Chinese herbal medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny | |
CN1586547A (en) | Medicine for treating bone wound | |
CN1091609C (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
CN101450197B (en) | Traditional Chinese medicine for treating rheumatism, rheumatoid disease | |
CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
CN1429616A (en) | New preparation of compound Chinese medicine for treating osteoarthritis and its preparation method | |
CN106266939A (en) | A kind of Chinese medicine composition, the transdermal patch for neck waist rehabilitation comprising this Chinese medicine composition and preparation and application | |
CN107375845A (en) | External composition for dispelling wind, eliminating dampness, clearing and activating channels and collaterals and use method thereof | |
CN103800489A (en) | Traditional Chinese medicine wine for treating cervical spondylosis and preparation method of traditional Chinese medicine wine | |
CN106177819A (en) | A kind of external medicine composition for cervical spondylosis, preparation method and applications | |
CN103041108B (en) | Medicinal liquor and preparation method thereof | |
CN1086298C (en) | Ointment for rheumatic spur | |
CN1247086A (en) | Process for making medical wine for treating rheumatism | |
CN1840164A (en) | Plaster for treating spur caused by wind-coldness | |
CN1772245A (en) | Snake medicinal wine for health care massage and its application | |
CN1261131C (en) | Medicinal plaster for treating cervical vertebra disease | |
CN1063338C (en) | Traditional Chinese medicine preparation for curing cervical and lumbar hyperosteogeny | |
CN105688059A (en) | Traditional Chinese medicine preparation with folium artemisiae argyi for treating osteoproliferation through external application | |
CN105232942A (en) | Traditional Chinese medicine compound treating generalized dystonia | |
CN1200724C (en) | Pill for activating collateral flow and removing spur | |
CN105311559A (en) | Medicinal liquor for treating scapulohumeral periarthritis | |
CN1286105A (en) | Moxiburning medicine for acupoint therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |